HP
Hepion Pharmaceuticals, Inc.
SEC filingBiotechnology · Red Bank, NJ
Amount raised$3.1Msold at filing
Total offering$3.1M
Investors in the raise33count reported to the SEC
FiledAug 5, 2026first sale Jul 31, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Gary S. Stetz, IIDirector
Gary StetzExecutive Officer, Director
Sireesh AppajosyulaDirector
Dania FisherDirector
Vincent LoPrioreExecutive Officer, Director
Chase LoPrioreDirector
Michael PurcellDirector
Executive officers, directors and promoters as listed on the Form D.